BlueLight Analytics builds innovative products that improve outcomes from light curing of dental fillings and promote value-based care in dentistry. The company’s technologies have been used to achieve thousands of light evaluations in over 35 countries. BlueLight Analytics will use and leverage the $3 million to continue to scale up its operations, accelerate product development and innovation, expand its global reach, and invest in strategic sales and marketing resources—all of which underpin its strategy to become the authority in light energy measurement.
JP Furey, CEO of BlueLight Analytics explained, “Our large database of light evaluations is growing daily, which creates opportunities for new technologies and offerings. Machine learning and data science will make it possible for us to significantly increase our new product development over the next 12 months.”
“We were drawn to BlueLight’s vision, aimed at improving dental patient care, and impressed by the company’s ability to attract the interest of important industry players. We are excited to partner with JP’s team and Innovacorp to support BlueLight in accelerating its growth,” said Nicola Urbani, principal at Crédit Mutuel Equity.
“Our team is dedicated to supporting companies like BlueLight, with deep technological expertise positioned in high growth potential sectors. As a value-added partner, Crédit Mutuel Equity actively contributes to the acceleration of their commercialization phase and can support their international expansion,” said Ludovic André, managing director of Crédit Mutuel Equity.
“BlueLight’s technology has significant potential to become part of a new standard of care for light curing in dental practice. Innovacorp is excited to partner with BlueLight and Crédit Mutuel Equity in bringing this disruptive technology to market,” said Robert Burns, Investment Manager at Innovacorp.
“We welcome our new investors and partners in BlueLight Analytics. Both Crédit Mutuel Equity and Innovacorp bring unique global and regional insights, proven execution capabilities, and other resources we consider critical to realizing our mission to help dentists deliver the highest quality patient outcomes. We will continue to innovate our technologies and expand globally,” added JP Furey.
